Cohen JA, Comi G, Selmaj KW, et al. Ozanimod vs interferon β-1a: clinical and MRI results of RADIANCE part B - A 2-year Phase 3 trial in relapsing multiple sclerosis. ECTRIMS 2017, 280.
Biobank ideale bron voor onderzoek naar COVID-19
sep 2020 | Dementie, Multipele Sclerose, Neuro-musculair